Guidelines

Useful links and downloads for further learning about multiple myeloma and its management.

Guidelines

Multiple myeloma guidelines in the UK

Dr Guy Pratt discusses what the aims of the Myeloma diagnosis and management NICE guidelines in the UK.

Watch the video »
  • National Institute for Health and Care Excellence (NICE)

    Myeloma overview – NICE Pathways

  • National Institute for Health and Care Excellence (NICE)

    Myeloma: diagnosis and management (NG35). Updated in October 2018

  • Guidelines for the use of imaging in the management of patients with myeloma

    Chantry A et al. British Journal of Haematology 2017; 178(3): 380–393

  • Guidelines for screening and management of late and long-term consequences of myeloma and its treatment

    Snowden JA et al. British Journal of Haematology 2017; 176(6): 888–907

  • Updates to the guidelines for the diagnosis and management of multiple myeloma 2014

    Pratt G et al. British Journal of Haematology 2014; 167: 131–133

  • United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma

    Rabin N et al. International Journal of Laboratory Hematology 2014; 36:665–675

  • British Committee for Standards in Haematology (BCSH) and the UK Myeloma Forum (UKMF): Guidelines for the diagnosis and management of multiple myeloma 2011

    Bird JM et al. British Journal of Haematology 2011; 154: 32–75

  • BCSH and the UKMF: Guidelines for supportive care in multiple myeloma 2011

    Snowden JA et al. British Journal of Haematology 2011; 154: 76–103

  • NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

    Kumar SK et al. Journal of the National Comprehensive Cancer Network 2018; 16(1): 11–20

  • Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

    Kumar SK et al. Journal of the National Comprehensive Cancer Network 2017; 15(2): 230–269

  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Moreau P et al. Annals of Oncology 2017; 28; iv52–iv61

  • European Myeloma Network recommendation on tools for diagnosis and monitoring of multiple myeloma: What to use and when

    Caers J et al. Haematologica 2018; 103; doi: 10.3324/haematol.2018.189159 (E-pub ahead of print)

  • European Myeloma Network guidelines for the management of multiple myeloma-related complications

    Terpos E et al. Haematologica 2015; 100: 1254–1266

  • European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

    Engelhardt M et al. Haematologica 2014; 99: 232–242

  • Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    Cavo M et al. Lancet Oncology 2017; 18(4): e206–e217

  • Second primary malignancies in multiple myeloma: an overview and IMWG consensus

    Musto P et al. Annals of Oncology 2017; 28(2): 228–245

  • Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

    Laubach J et al. Leukemia 2016; 30:1005–1017

  • International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment

    Dimopoulos MA et al. Journal of Clinical Oncology 2016; 34:1544–1557

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Kumar S et al. Lancet Oncology 2016; 17: e328–46

  • Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

    Dimopoulos MA et al. Journal of Clinical Oncology 2015; 33:657–664

  • International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation

    Palumbo A et al. Journal of Clinical Oncology 2014; 32(6): 587–600

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    Rajkumar SV et al. Lancet Oncology 2014; 15: e538–548

  • International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease

    Terpos E et al. Journal of Clinical Oncology 2013; 31: 2347–2357

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.